Answers are grounded in this paper and cite their sources.
Ga-NOTA-DGL-PEG-RGDyC had good targeting and can be enriched in tumor sites. Through hemolysis testing and morphological changes of red blood cells, it was proved that NOTA-DGL-PEG-RGDyC has good blood compatibility.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: